Creative Biolabs-Immuno-oncology

Anti-DR5 (clone HS2E0Z1G) SynExpress SV-Cy2-cJ-H Modified CD8+ T cells (CAT#: ITS-1224-CR2293)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DR5 (clone HS2E0Z1G). We employs the Lentivirus (SV40-Cy2-c-Jun-HindIII) vector components and the SynExpress system of the Coding regions Deletion/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
DR5
Clone
HS2E0Z1G
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy2
Promoter
SV40
Effector Gene
c-Jun
Insertion Sites
HindIII
Gene Modification
Deletion
Modification Domain
Coding regions
Carrier Type
Lentivirus
Transformation Accuracy
0.95
Cell Culture
3D Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.